Ralph Kern's most recent trade in Brainstorm Cell Therapeutics, Inc. was a trade of 35,885 Common Stock done . Disclosure was reported to the exchange on March 6, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Brainstorm Cell Therapeuti... | Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2022 | 35,885 | 223,310 (0%) | 0% | 0 | Common Stock |